Cargando…
Erratum for “Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy”
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692221/ https://www.ncbi.nlm.nih.gov/pubmed/34655107 http://dx.doi.org/10.1111/jvim.16287 |
| _version_ | 1784618913748746240 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8692221 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86922212022-01-03 Erratum for “Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy” J Vet Intern Med Erratum John Wiley & Sons, Inc. 2021-10-15 2021 /pmc/articles/PMC8692221/ /pubmed/34655107 http://dx.doi.org/10.1111/jvim.16287 Text en © 2021 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC. on behalf of the American College of Veterinary Internal Medicine. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Erratum Erratum for “Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy” |
| title | Erratum for “Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy” |
| title_full | Erratum for “Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy” |
| title_fullStr | Erratum for “Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy” |
| title_full_unstemmed | Erratum for “Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy” |
| title_short | Erratum for “Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy” |
| title_sort | erratum for “adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy” |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692221/ https://www.ncbi.nlm.nih.gov/pubmed/34655107 http://dx.doi.org/10.1111/jvim.16287 |